Mirscience Tx aims to improve the quality of life of patients by developing therapies that act on life-long illnesses.
Mirscience Therapeutics is a precision medicine start-up that develops therapies for lifelong illnesses, such as the ones that cause fraily and muscle atrophy; metabolic like non-alcoholic fatty liver disease (NASH), and cancer.
Using their MIR-Discovery platform, the company acts by discovering and developing MicroRNA molecules- a small endogenous RNA molecule found in our organism with many roles in various physiological functions and in emerging diseases- as potential and specific therapeutic targets for each disease. Currently, the company acts with the development of a therapy that target MURF-1 and Atrogin-1. Both targets are responsible for atrophy and muscle frailty in diseases like sarcopenia, caquexia induced by cancer, and muscle atrophy related to orthopaedic lesion.
Our molecule shows, during pre-clinical tests, an anti-atrophic effect, hypertrophy and functional improvement of the skeletal muscle.
Transform the lives of people struggling with diseases that undermine quality of life.
Our Work Is Heavily Shaped by Our Core Values
Safe, specific and accessible
Through our technology, to develop molecules capable of inhibiting their targets in a safe, specific and accessible.
Quality of life
Improving the lives of patients, families, communities which creates a well-being chain reaction.